Navigation Links
Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
Date:10/8/2009

CHADDS FORD, Pa., Oct. 8 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its third quarter financial results on October 29, 2009 and will host a conference call and webcast at 9:00 a.m. ET that day to discuss these results.

David P. Holveck, president and chief executive officer, Ivan Gergel, M.D., executive vice president of research and development, Alan Levin, chief financial officer and Blaine Davis, vice president, corporate affairs will host the call.

Investors and other interested parties may call 800-798-2884 (domestic) or 617-614-6207 (international) and enter passcode 12555118. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from October 29 at 12:00 p.m. ET until 12:00 a.m. ET on November 4 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 66458151.

A simultaneous webcast of the call may be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 12:00 a.m. ET on November 4. The replay can be accessed by clicking on "Upcoming Events" in the Investor Relations section of the website.

About Endo

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Its products include LIDODERM®, a topical patch to relieve the pain of postherpetic neuralgia; Percocet® and Percodan® tablets for the relief of moderate-to-moderately severe pain; FROVA® tablets for the acute treatment of migraine attacks with or
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
2. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
5. Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray
6. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
7. Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates
8. Merz Pharmaceuticals Announces Phase III Data for NT 201 in Post-stroke Upper Limb Spasticity
9. Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)
10. Conatus Pharmaceuticals to Present at the Montgomery Healthcare Conference
11. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... REDMOND, Washington , 29. Juli 2015 ... deutschen Diabeteszentrums wurde festgestellt, dass die tägliche ... von Nutraceutix die menschliche Darmflora anreichert und ... Insulinsekretion erhöhen. Die Studie umfasste die tägliche ... (ATCC-Stamm SD-5865) in Tablettenform unter Verwendung der ...
(Date:7/29/2015)... 29, 2015 Touro College has announced that it ... for one of five media marijuana licenses to be issued ... of Health (DOH).  If CanniCare is selected, ... "Our college is supportive of medicinal development ... the Touro College System. "There is still a great deal ...
(Date:7/29/2015)... , July 29, 2015  AcelRx Pharmaceuticals, ... company focused on the development and commercialization of ... breakthrough pain, today announced that it will release ... Monday, Aug 3rd, 2015. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on Aug 3rd, ...
Breaking Medicine Technology:Klinischer Nachweis erbracht, dass L. reuteri Probiotikum von Nutraceutix den Darm-Insulinmetabolismus moduliert 2Touro College Announces Support for CanniCare's Medical Cannabis License Application 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 2AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 3AcelRx Pharmaceuticals to Hold Business Update and Second Quarter Financial Results Conference Call and Webcast on Monday, Aug. 3rd, 2015. 4
... at TCT 2007; EVEREST II Study ... Enrollment Continues, ... a successful result with the percutaneous MitraClip device did not need,mitral ... improved function of the left ventricle (commonly known,as reverse remodeling), according ...
... Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: WYE ... Administration (FDA) has accepted for filing the,Company,s supplemental ... (tigecycline) for the treatment of patients with,community-acquired pneumonia ... of,the application. The FDA may approve or disapprove ...
Cached Medicine Technology:New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 2New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 3New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 4New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 5FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 2FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 3FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 4FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 5FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia 6
(Date:7/29/2015)... ... July 29, 2015 , ... More than ... service providers of children living with autism will converge upon Penn State to ... , The National Autism Conference will be held Aug. 3-6 at the ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business on ... directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the same gene, ... the National academy of Sciences, and has given researchers inklings to explore Rsu1 in ...
(Date:7/29/2015)... ... 2015 , ... With a new community program in the ... Support Services and announced a new charity campaign to raise funds to support ... workshops and educational programs at no charge. Scott Campbell Agency initiates this ...
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... Wedding season is in ... wedding bells comes the extra pressure of looking good on the big day. Every bride ... pre-wedding prep to a new level. , According to a recent study ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a prominent orthopedic ... treatments to qualifying patients with demonstrated financial need. , “We are thrilled for ...
Breaking Medicine News(10 mins):Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2
... technique -- intrauterine insemination with controlled ovarian hyperstimulation – is ... way, for some couples. ,The results of the ... ,The research was conducted on 253 couples with unexplained infertility ... were cases where no obvious abnormalities were found. ...
... develop multiple sclerosis (MS) in comparison to non-diabetic people, ... and MS are auto-immune diseases, where the body builds ... cells in patients with diabetes, and the myelin sheath ... , Dr. Nete M. Nielsen, from the Statens ...
... chemical used to thicken everything from baby food to ... cervical cancer// and genital warts. ,Researchers found ... attaching to cells in laboratory tests. Certain strains of ... ,In the study conducted by researchers from the ...
... CPMT-06 arrived at the counseling centre on GSVM Medical ... access counseling process online// and perhaps this has meant ... available on the website www.upcpmt.nic.in. But students were dissatisfied ... after many attempts they were unable to find the ...
... in Bhopal and two of its doctors have been asked ... fine for alleged// post-operative negligence resulting in the death of ... to Ayushman Hospital following swelling in her uterus and respiratory ... uterus. Since the tumor was not malignant and the possibility ...
... pockets of the North Eastern region have the highest cancer ... country, a study done by the National Cancer Registry Programme ... maximum number of tongue cancer surpassing the figure of Bhopal ... ago, Dr A Nandkumar, NCRP officer in-charge told a medical ...
Cached Medicine News:Health News:Common Chemical From Seaweed Could Help In The Fight Against Cervical Cancer Virus-HPV 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: